Discovery
University of Illinois advances multivalent ETEC vaccine designed to target both toxins and adhesins
University of Illinois Urbana-Champaign has received a USD 1.12 million NIAID R01 grant to advance MecVax, a multivalent subunit vaccine candidate targeting...
NIH funds Michigan State Uni study for antibody-switching mechanism linked to B cell lymphoma
Henry Ford Health + Michigan State University Health Sciences has received a USD 2.86 million NIH R01 grant from the National Institute of Allergy and...
Cognision research points to baseline EEG signature guiding to hidden responder groups in ketamine challenge studies
Researchers at Louisville, Kentucky-based Cognision (Nasdaq: not listed), working through the EEG/ERP Biomarker Qualification Consortium, report that an...
KAIST, Chungnam National Uni use organoid platform to identify lazertinib's utility in glioblastoma
A functional drug-screening platform built on patient-derived glioblastoma organoids predicted individual patient responses to temozolomide more accurately...
Dana-Farber Cancer Institute receives USD 50m Yawkey Foundation grant for Boston hospital
Dana-Farber Cancer Institute has received a USD 50 million philanthropic grant from the Yawkey Foundation to support construction of a planned 300-bed...
University of Minnesota wins NIH support for CAR Treg and lipid nanoparticle cGVHD therapies
The University of Minnesota has received a USD 1.58 million NIH R01 grant from the National Heart, Lung, and Blood Institute to investigate the cellular...
Novoron Bio's Alzheimer's tau screening platform supported by NIH monies
San Diego-based Novoron Bioscience, Inc. has received a USD 1.25 million NIH R44 SBIR grant from the National Institute on Aging to develop a human...
Icahn School of Medicine at Mount Sinai picks up NIH funding for mRNA-lipid nanoparticle rotator cuff therapy
Icahn School of Medicine at Mount Sinai has received a USD 2.06 million NIH R01 grant to develop an mRNA-lipid nanoparticle therapy targeting muscle...
Sur180 Therapeutics gets NIH SBIR grant to advance CRH antagonist for endometriosis
Sur180 Therapeutics receives USD 1.14 million NIH SBIR grant to advance CRH antagonist for endometriosis
University of Georgia backed with USD 1.47m NIA award for engineered bacterial Alzheimer's therapeutic
The University of Georgia has received a USD 1.47 million National Institute on Aging U01 continuation award to advance preclinical development of a...
UCSF backed with NIA grant to explore IL-6 signaling, olamkicept in Alzheimer's
The University of California, San Francisco has received a USD 1.07 million National Institute on Aging R01 award to investigate whether IL-6...
AbVacc receives USD 1m NIH award for Marburg antibody cocktail advancement
NIH backs Marburg antibody cocktail in continued SBIR support for AbVacc
Yale University secures USD 3.3m NIH grant for NgR1 inhibitor in spinal cord injury trial
Yale University has received a USD 3.3 million NIH UG3 grant to advance a Phase II clinical trial of AXER-204, a Nogo-66 Receptor 1 (NgR1) pathway...
Weill Cornell Medical College receives USD 3.6m NIH grant for tuberculosis treatment duration research
Weill Cornell Medical College has received a USD 3.6 million NIH Program Project grant to investigate the microbial determinants of tuberculosis treatment...
Lysoway Therapeutics secures USD 3.4m Michael J. Fox Foundation grant for TMEM175 Parkinson's program
Lysoway Therapeutics, a Cambridge, Massachusetts-based biopharmaceutical company focused on lysosomal ion channel modulators, has received approximately USD...
The AllSci Brief
Free, systematic R&D and deal news. Daily.